BioWorld

April 27, 2006

HIV Study Adding African Site For Targeted Genetics' Product

HIV researchers are enlisting a gene therapy product in an expanding study that's under way in southern Africa. (BioWorld Today) Read More

Alkermes Starts Phase III Of Inhaled Insulin Product

FivePrime, BI Enter Deal In RA Worth Up To $75M

For Replikins, Replication Data Allow For Predicting Epidemics

Clinic Roundup

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for July 24, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for July 21, 2026

To viral or not to viral: In vivo CAR T debates delivery tech

BioWorld Science

The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...

To viral or not to viral: In vivo CAR T debates delivery tech

BioWorld Asia

The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...

Other news to note for July 22, 2026

BioWorld

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...